title: Endothelin-1 could be one of the targets of psoriasis therapy.
authors.forename: P
authors.initials: P
authors.lastname: Simeone
authors.forename: M
authors.initials: M
authors.lastname: Teson
authors.forename: A
authors.initials: A
authors.lastname: Latini
authors.forename: M
authors.initials: M
authors.lastname: Carducci
authors.forename: A
authors.initials: A
authors.lastname: Venuti
mesh_terms: D000077868:Atrasentan; D002478:Cells, Cultured; D003879:Dermatologic Agents / Q000494:pharmacology*; D019332:Endothelin-1 / Q000037:antagonists & inhibitors*; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D011759:Pyrrolidines / Q000494:pharmacology
chemical_list: D003879:Dermatologic Agents; D019332:Endothelin-1; D011759:Pyrrolidines; D000077868:Atrasentan